| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |